Clinical trial Recruiting at 1 site Interventional Ages 70 and up

Tool for assessing memory in older adults

Official title: Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics: an Adaptation of the Memory Test With Self-Initiated Items (MAI)

Run by Centre Hospitalier de Lens · NCT05668598 · Data updated 2026-11-12

This study is testing a new memory tool for older adults aged 70 and up to see if it can help spot early signs of memory problems, especially in those with or without neurocognitive disorders.

Quick facts

Study typeInterventional
Ages70 Years and up
SexAll
Enrollment60 (estimated)
SponsorCentre Hospitalier de Lens
Academic / other
Locations1 site (Lens)
StatusRecruiting
StartedMarch 8, 2023
Main results expectedMarch 8, 2028
Study endsMarch 9, 2028
Registry record updatedMay 8, 2026
Trial IDNCT05668598 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are males and females aged 70 and older who can move independently and agree to participate.

Probably not a fit

Patients with severe cognitive impairment, legal protective measures, or significant visual disturbances may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study recruits participants aged 70 and older to assess their episodic memory using an ecological MAI test. Participants are divided into two groups: those with neurocognitive disorders and those without. The study involves neuropsychological assessments to determine the presence of neurodegenerative diseases. The assessment takes 30 minutes for routine care patients and 2.5 hours for those recruited from external institutions. The goal is to enable early detection of cognitive anomalies in older adults.

Why it matters

Potential benefit: If successful, this study could lead to early detection and management of memory disorders in older adults.

How similar studies have gone: Other studies have shown success in using neuropsychological assessments for early detection of cognitive disorders, making this approach promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female ≥ 70 ans
* Person have good locomotion, move independently
* Personne agree to participate

Groupe 1 : 17≤MMSE≤24 (GRECO) Diagnosis of neurodegenerative diseases (major neurocognitive disorders: Alzheimer, mixed dementia, lobar frontotemporal degeneration, vascular dementia).

Groupe 2 : MMSE ≥ à 25 (GRECO) Without neurodegenerative disease

Exclusion Criteria:

* Person with legal protective measures
* Person deprived of liberty
* Mental retardation or MMSE≤ 16
* Understanding verbal disorders
* Visual major disturbances
* Person with disease causing increased fatigue
* Person with psychiatric pathology excepted anxiety disorder or depression with mild episodes.
* Person not covered by French national health insurance

Where it's running

  • Centre Hospiralier de Lens
    Lens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.